HBV DNA and HBsAg Levels at 24 Weeks Off-Treatment Predict Clinical Relapse and HBsAg Loss in HBeAg-Negative Patients Who Discontinued Antiviral Therapy
Milan J. Sonneveld(Erasmus MC), Benjamin Maasoumy(Medizinische Hochschule Hannover), Sang Hoon Ahn(Yonsei University), George Ν. Dalekos(University Hospital of Larissa), Yasuhito Tanaka(Kumamoto University), Nicole S. Erler(Erasmus MC), Ivana Carey(King's College London), Sylvia M. Brakenhoff(Erasmus MC), George Papatheodoridis(National and Kapodistrian University of Athens), Harry L.A. Janssen(Erasmus MC), Teerha Piratvisuth(Prince of Songkla University), Marı́a Buti(Vall d'Hebron Hospital Universitari), Fabien Zoulim(Hôpital de la Croix-Rousse), Man‐Fung Yuen(University of Hong Kong - Shenzhen Hospital), P. Colombatto(Azienda Ospedaliera Universitaria Pisana), Kosh Agarwal(King's College - North Carolina), Florian van Bömmel(University Hospital Leipzig), Apichat Kaewdech(Prince of Songkla University), Heiner Wedemeyer(Medizinische Hochschule Hannover), Μargarita Papatheodoridi(Laiko General Hospital of Athens), Maurizia Rossana Brunetto(University of Pisa), Thomas Berg(Leipzig University of Applied Sciences), Jun Yong Park(Yonsei University), Chien‐Hung Chen(Kaohsiung Chang Gung Memorial Hospital), Shao‐Ming Chiu(Kaohsiung Chang Gung Memorial Hospital), André Boonstra(Erasmus MC), Wai‐Kay Seto(State Key Laboratory of Synthetic Chemistry), Markus Cornberg(Medizinische Hochschule Hannover)
Cited by 23
Related Papers
ABT-450/r–Ombitasvir and Dasabuvir with Ribavirin for Hepatitis C with Cirrhosis
|New England Journal of Medicine|2014|877
Tremelimumab in combination with ablation in patients with advanced hepatocellular carcinoma
|Journal of Hepatology|2016|817
Hepatitis B Virus Resistance to Nucleos(t)ide Analogues
|Gastroenterology|2009|693
A Placebo-Controlled Trial of Bezafibrate in Primary Biliary Cholangitis
|New England Journal of Medicine|2018|605
Epidemiology of Hepatocellular Carcinoma in the Asia-Pacific Region
|Gut and Liver|2016|512